AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 175 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,665,569 | -59.4% | 90,965 | -52.2% | 0.00% | – |
| Q2 2023 | $4,104,685 | +37.6% | 190,296 | +87.1% | 0.00% | – |
| Q1 2023 | $2,984,000 | +162427.2% | 101,700 | +104.6% | 0.00% | – |
| Q4 2022 | $1,836 | -99.7% | 49,701 | +158.0% | 0.00% | – |
| Q3 2022 | $542,000 | +359.3% | 19,264 | +214.2% | 0.00% | – |
| Q2 2022 | $118,000 | +103.4% | 6,132 | +36.4% | 0.00% | – |
| Q1 2022 | $58,000 | – | 4,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
| Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
| GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
| Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
| Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
| Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
| EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
| SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |